R

Rallybio Corp
NASDAQ:RLYB

Watchlist Manager
Rallybio Corp
NASDAQ:RLYB
Watchlist
Price: 0.675 USD -0.15%
Market Cap: 28.5m USD

Wall Street
Price Targets

RLYB Price Targets Summary
Rallybio Corp

Wall Street analysts forecast RLYB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RLYB is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Lowest
Price Target
1.01 USD
50% Upside
Average
Price Target
1.02 USD
51% Upside
Highest
Price Target
1.05 USD
56% Upside
Rallybio Corp Competitors:
Price Targets
BVXP
Bioventix PLC
116% Upside
QTTB
Homology Medicines Inc
221% Upside
IVA
Inventiva SA
157% Upside
RPTX
Repare Therapeutics Inc
19% Upside
SLS
Sellas Life Sciences Group Inc
78% Upside
CNTB
Connect Biopharma Holdings Ltd
250% Upside
AVCT
Avacta Group PLC
45% Upside
VRTX
Vertex Pharmaceuticals Inc
15% Upside

Revenue
Forecast

Revenue Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rallybio Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLYB's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for RLYB is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Back to Top